Arcosa (ACA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Mar, 2026Executive summary
Annual meeting scheduled for May 13, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 12, 2026.
Voting matters and shareholder proposals
Election of nine directors to the board is up for shareholder vote.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Nine nominees are presented for election to the board, including Joseph Alvarado, Rhys J. Best, Antonio Carrillo, Jeffrey A. Craig, Steven J. Demetriou, John W. Lindsay, Kimberly S. Lubel, Julie A. Piggott, and Melanie M. Trent.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Arcosa
- Record financial results, strong governance, and sustainability milestones highlighted.ACA
Proxy filing31 Mar 2026 - Record 2025 growth, barge divestiture, and strong 2026 EBITDA outlook with margin expansion.ACA
Q4 202527 Feb 2026 - Record Q2 results, $1.2B Stavola deal, and portfolio actions drive growth and margin gains.ACA
Q2 20242 Feb 2026 - Transformational acquisition boosts aggregates to 65% of EBITDA, fueling growth and margin expansion.ACA
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 2024 Adjusted EBITDA rose 39% with margin gains and raised guidance after major portfolio moves.ACA
Q3 202417 Jan 2026 - Double-digit growth, margin expansion, and strong cash flow set up 30% EBITDA growth for 2025.ACA
Q4 202421 Dec 2025 - Strong financials, board independence, and sustainability drive 2025 proxy proposals.ACA
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve executive pay, and ratify auditor, all board-backed.ACA
Proxy Filing1 Dec 2025 - Record Q2 2025 revenue and margin growth, with robust outlook and strong segment performance.ACA
Q2 202523 Nov 2025